kawasaki
diseas
kd
acut
febril
ill
childhood
characteris
vascul
mediums
arteri
special
predilect
affect
coronari
arteri
first
describ
dr
tomisaku
kawasaki
japan
coronari
arteri
involv
cardiac
morbid
subsequ
realis
autopsi
conduct
patient
kd
sinc
world
kd
recognis
lead
caus
acquir
heart
diseas
especi
develop
countri
higher
incid
japanes
children
kd
rare
infant
age
month
infant
describ
atyp
prolong
sever
manifest
kd
commonli
refractori
standard
therapi
herein
describ
kd
infant
patient
diagnos
treat
earli
infliximab
altern
rescu
therapi
produc
dramat
clinic
respons
case
report
femal
infant
patient
brought
hospit
complaint
highgrad
fever
day
durat
macular
rash
promin
upper
part
bodi
extrem
irrit
sever
diarrhoea
histori
seizur
lethargi
increas
chest
activ
abdomin
distens
examin
found
irrit
highgrad
continu
fever
initi
manag
case
sepsi
broadspectrum
antibiot
despit
continu
symptomat
admiss
anaemia
haemoglobin
gmdl
polymorphonuclear
leucocytosi
total
leucocyt
count
mm
neutrophil
normal
platelet
count
rais
creactiv
protein
crp
mgl
erythrocyt
sediment
rate
esr
mmh
cerebrospin
fluid
analysi
normal
workup
includ
urin
blood
cultur
abdomin
ultrasonographi
normal
show
poor
respons
therapi
includ
gradat
parenter
antibiot
view
altern
diagnosi
sought
day
ill
notic
rightsid
nontend
cervic
lymphadenopathi
measur
cm
cm
bilater
nonpurul
conjunct
erythema
lip
tongu
day
later
patient
also
develop
extens
perin
desquam
fig
stage
possibl
clinic
diagnosi
kd
entertain
esr
crp
show
rise
titr
mmh
mgl
respect
day
ill
thrombocytosi
platelet
count
lacmm
develop
twodimension
echocardiographi
stage
normal
standard
dose
gmkg
intraven
immunoglobulin
infus
h
show
partial
respons
term
defervesc
view
second
dose
intraven
immunoglobulin
ivig
gmkg
administ
along
antiinflammatori
dose
acetyl
salicyl
acid
mgkg
howev
exhibit
poor
clinic
respons
continu
febril
stage
earli
week
ill
develop
desquam
skin
hand
feet
repeat
haematolog
paramet
reveal
worsen
anaemia
hb
gm
polymorphonuclear
leucocytosi
total
leucocyt
count
thrombocytosi
platelet
count
hypoalbuminemia
serum
albumin
gm
dl
peripher
blood
smear
show
shift
left
vacuol
leucocyt
repeat
echocardiographi
also
reveal
abnorm
thrombocytosi
show
increas
trend
ensu
day
view
signific
clinic
improv
administ
inj
methylprednisolon
mgkg
day
follow
although
remain
afebril
h
fever
recur
later
second
week
ill
inj
infliximab
mgkg
administ
rescu
measur
follow
becam
afebril
within
h
recurr
fever
thereaft
repeat
echocardiographi
junctur
end
week
reveal
larg
coronari
aneurysm
involv
right
coronari
arteri
rca
left
main
coronari
arteri
lmca
left
anterior
descend
coronari
arteri
ladca
left
circumflex
coronari
arteri
lcxca
fig
normal
biventricular
systol
diastol
function
mild
pericardi
effus
electrocardiogram
normal
oral
steroid
inject
lowmolecularweight
heparin
also
ad
discharg
serial
echocardiographi
studi
followup
reveal
gradual
signific
reduct
size
coronari
arteri
aneurysm
caa
month
complet
regress
month
tabl
continu
antiplatelet
dose
acetyl
salicyl
acid
throughout
followup
kawasaki
diseas
idiopath
multisystem
diseas
involv
acut
vascul
mainli
mediums
vessel
characterist
coronari
arteri
commonest
caus
acquir
heart
diseas
children
usa
japan
major
case
affect
children
age
year
rare
young
infant
children
older
year
last
year
kd
increasingli
recognis
india
may
soon
replac
acut
rheumat
fever
becom
commonest
caus
acquir
heart
diseas
among
children
pauciti
indian
data
kd
young
infant
although
clinic
diagnost
criteria
exist
diagnos
typic
kd
atyp
form
diseas
may
incomplet
clinic
pictur
aetiolog
kd
remain
enigma
even
though
diseas
known
year
variou
aetiolog
factor
genet
immunolog
infecti
agent
new
coronaviru
epsteinebarr
viru
bocaviru
adenoviru
yersinia
psuedotuberculosi
implic
probabl
interplay
mani
factor
role
infecti
agent
genet
suscept
host
youngest
patient
report
neonat
report
incid
kd
infant
younger
month
diseas
extrem
rare
infant
younger
month
incid
patient
younger
year
frequent
high
white
blood
cell
count
steril
pyuria
less
neck
lympadenopathi
mani
infant
present
atyp
kd
consid
children
age
year
less
prolong
fever
extrem
platelet
count
elev
compel
altern
diagnosi
infant
younger
month
prolong
unexplain
febril
ill
suspect
kd
despit
incomplet
clinic
present
may
rare
clinic
featur
includ
abdomin
pain
diarrhoea
vomit
upper
respiratori
tract
infect
steril
pyuria
rare
intussuscept
hydrop
gallbladd
atyp
present
patient
includ
diarrhoea
featur
suggest
sepsi
patient
also
typic
cervic
lymphadenopathi
incid
found
low
studi
one
studi
longer
durat
fever
incomplet
clinic
manifest
infant
significantli
associ
develop
coronari
arteri
abnorm
hallmark
kd
involv
coronari
arteri
although
clinic
featur
kd
resolv
acut
ill
risk
develop
caa
approxim
four
time
higher
children
receiv
standard
ivig
treatment
vs
therefor
primari
aim
treat
physician
earli
recognit
kd
administr
ivig
consider
altern
therapi
poor
respons
standard
treatment
differ
score
system
describ
identifi
patient
high
risk
unrespons
ivig
therapi
despit
earli
treatment
ivig
patient
kd
show
respons
first
dose
ivig
patient
offer
repeat
dose
ivig
patient
would
still
refractori
treatment
guidelin
american
heart
associ
recommend
second
dose
ivig
methylprednisolon
longer
taper
cours
prednisolon
prednison
plu
ivig
infliximab
cyclosporin
immunomodulatori
monoclon
antibodi
therapi
cytotox
agent
plasma
exchang
patient
resist
ivig
patient
treat
infliximab
demonstr
fall
inflammatori
marker
interleukin
il
tnfr
correspond
reduct
fever
without
advers
effect
infliximab
chimer
mousehuman
monoclon
antibodi
direct
solubl
membranebound
tumour
necrosi
factoralpha
howev
randomis
control
trial
adriana
et
al
demonstr
addit
infliximab
standard
therapi
patient
typic
kd
year
reduc
treatment
resist
reduc
fever
durat
inflammatori
marker
importantli
risk
develop
lad
caa
case
report
demonstr
superior
ivig
term
reduct
fever
durat
although
similar
role
prevent
caa
question
recommend
dose
infliximab
dose
mgkg
infus
iv
day
h
day
case
infliximab
administ
failur
respons
two
dose
ivig
methylprednisolon
infliximab
emerg
altern
therapi
good
clinic
respons
patient
refractori
standard
therapi
howev
larger
adequ
power
trial
requir
recommend
infliximab
therapi
earli
altern
second
dose
ivig
resist
infantil
case
kd
prevent
caa
author
none
declar
